Last reviewed · How we verify

NCT04378036

Hippotherapy Simulator in Children With Cerebral Palsy

Completed NA Last updated 8 May 2020
What this trial tests

NA trial testing Neurodevelopmental Therapy in Rehabilitation in 30 participants. Completed in 28 October 2017.

Timeline
14 December 2016
Primary endpoint
28 October 2017
28 October 2017

Quick facts

Lead sponsorMarmara University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date14 December 2016
Primary completion28 October 2017
Estimated completion28 October 2017
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 5 to 18, any sex, with Rehabilitation or Cerebral Palsy, Spastic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to research the effects of hippotherapy simulator in children with Cerebral Palsy. In order to evaluate its effectiveness, assessment of gross motor functions, lower extremity functions, muscle tone and spasticity, trunk control, sitting and standing balance, walking functions and functional independence were being applied.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Effect of Hippotherapy Simulator-Assisted Therapy on Motor and Functional Outcomes in Children with Cerebral Palsy.
    Günay Yazıcı C, Özden F, Çoban O, Tarakçı D, et al · · 2025 · PMID 41155798 · DOI 10.3390/medicina61101811

Verify or expand the search:

Other trials of Neurodevelopmental Therapy

Trials testing the same drug.

Other recruiting trials for Rehabilitation

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04378036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing